PMV Pharmaceuticals Inc. (NASDAQ: PMVP)
$1.69
+0.0550 ( +3.37% ) 348.8K
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Market Data
Open
$1.69
Previous close
$1.63
Volume
348.8K
Market cap
$86.43M
Day range
$1.61 - $1.73
52 week range
$1.18 - $9.72
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 24, 2024 |
| 10-k | Annual reports | 100 | Feb 29, 2024 |
| 8-k | 8K-related | 13 | Feb 29, 2024 |
| 4 | Insider transactions | 2 | Jan 22, 2024 |
| 4 | Insider transactions | 1 | Jan 22, 2024 |
| 4 | Insider transactions | 2 | Jan 22, 2024 |
| 8-k | 8K-related | 13 | Jan 18, 2024 |
| 3 | Insider transactions | 2 | Jan 11, 2024 |
| 8-k | 8K-related | 13 | Jan 05, 2024 |
| 4 | Insider transactions | 1 | Nov 24, 2023 |